SAN DIEGO, March 28, 2019 – ivWatch will showcase their solution that aids in the early detection of a common complication of peripheral intravenous (IV) therapy at the 2019 American Organization of Nurse Executives (AONE) Annual Meeting and Exposition on April 10-13, 2019 in San Diego. As part of ongoing efforts to educate on the prevalence of IV complications and the importance of surveillance monitoring to improve patient safety, the company will host open in-booth presentations for attendees to learn more about the economic impacts of peripheral IV infiltration/extravasation injuries. The session, “Infiltration Impact on Quality and Cost of Care” facilitated by Susan Brown MSN, MSED, VA-BC, the chief nursing officer at ivWatch, will repeat in the company’s booth (#412) during
regular exhibition hall hours on:
April 11: 10:00 a.m. and 12:30 p.m.
April 12: 10:00 a.m. and 12:30 p.m.
“Complications from peripheral IV’s have recently been addressed as a systemic issue facing health systems by the independent patient-safety organization, ECRI Institute, in their Top 10 Patient Safety Concerns for 2019 report*,” said Brown. “I am thrilled to have the opportunity to speak with nursing leadership from across the country on the new advancements in vascular access, and how to harness technology to improve quality and outcomes in this area.” Additionally, the ivWatch Model 400 will be featured in-booth. The first-of-its-kind continuous monitoring device offers early detection of infiltrations/extravasations, minimizing the risks of IV therapy.
To learn more about ivWatch and upcoming event participation, visit ivwatch.com/events/.
ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians are able to leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC, or visit www.ivWatch.com.